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Electroacupuncture preconditioning
reduces ROS generation with NOX4 down-
regulation and ameliorates blood-brain
barrier disruption after ischemic stroke
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Abstract
Background: Electroacupuncture (EA) is a modern application based on combination of traditional manual
acupuncture and electrotherapy that is frequently recommended as an adjuvant treatment for ischemic stroke.
EA preconditioning can ameliorate blood-brain barrier (BBB) dysfunction and brain edema in ischemia-reperfusion
injury; however, its mechanism remains unclear. This study investigated the preventive effects of EA preconditioning,
particularly on BBB injury, followed by a transient middle cerebral artery occlusion (MCAO) model in mice.
Results: Mice were treated with EA (20 min) at Baihui (GV20) and Dazhui (GV14) acupoints once a day for 3 days
before ischemic injury. Infarct volume, neurological deficits, oxidative stress, Evans blue leakage and brain edema were
evaluated at 24 h after ischemia-reperfusion injury. EA preconditioning significantly decreased infarct volume and
improved neurological function even after ischemic injury. In addition, both Evans blue leakage and water content
were significantly reduced in EA preconditioned mice. Whereas the expression of tight junction proteins, ZO-1 and
claudin-5, were remarkably increased by EA preconditioning. Mice with EA preconditioning showed the reduction of
astrocytic aquaporin 4, which is involved in BBB permeabilization. In addition, we found that EA preconditioning
decreased reactive oxygen species (ROS) in brain tissues after ischemic injury. The expression of NADPH oxidase 4
(NOX4), not NOX2, was significantly suppressed in EA preconditioned mice.
Conclusions: These results suggest that EA preconditioning improve neural function after ischemic injury through
diminishing BBB disruption and brain edema. And, the reduction of ROS generation and NOX4 expression by EA
preconditioning might be involved in BBB recovery. Therefore, EA may serve as a potential preventive strategy for
patients at high risk of ischemic stroke.
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Background
Stroke, which is one of the most common pathologies,
has high morbidity and a high rate of long-term disabil-
ity in industrialized countries [27]. Electroacupuncture
(EA), which is the modern application of traditional acu-
puncture combined with electrotherapy, has been the
most well-known complementary and alternative clinical
approach to treatment of ischemic stroke for more than
3000 years. Although the clinical effectiveness of EA on
ischemic stroke has been widely affirmed, its mechanisms
of action are not fully understood. In animal experiments,
repeated EA treatments have been shown to accelerate
restoration of cerebral tissue lesion and function during
cerebral ischemia-reperfusion using microPET imaging
[25]. In addition, EA has been reported to induce brain is-
chemic tolerance via regulation of oxidative stress [45],
maintenance of the blood-brain barrier (BBB) integrity [5]
and inhibition of apoptosis through cannabinoid receptors
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[36, 37], adenosine receptor [38] and opiod receptors [39].
Our previous study showed that EA pretreatment induced
tolerance against cerebral ischemic injury via upregulation
of neurotrophic factors such as BDNF and SDF-1α [17].
However, more evidence is needed to suggest specific
therapeutic targets strongly correlated with EA precondi-
tioning, and the mechanism of cerebral ischemia tolerance
induced by EA preconditioning remains unclear.
Ischemic stroke involves complicated pathological pro-
cesses associated with multiple biological systems, the
combined action of which determines the outcome of the
ischemic event [27]. It is well known that brain edema is
caused by water accumulation in the brain because of BBB
disruption after ischemic stroke [42]; however, current
clinical therapeutic methods for its treatment remain un-
satisfactory. Cerebral ischemia-induced excessive produc-
tion of reactive oxygen species (ROS) has been shown to
be the main mechanism contributing to BBB disruption
[15] and NADPH oxidases (NOX) are the primary sources
of ROS following ischemic stroke, playing central roles in
post-stroke BBB disruption [13].
This study was conducted to investigate the role of EA
preconditioning in BBB dysfunction and brain damage
elicited by focal cerebral ischemia-reperfusion and to ex-
plore the potential mechanisms involved. To accomplish
this, we used a mouse model of middle cerebral artery
occlusion (MCAO) to assess whether EA precondition-
ing reduces infarct volume and neurological deficits and
if so, to elucidate whether the preventive effects are associ-
ated with inhibition of BBB disruption and brain edema,
as well as the underlying mechanisms.
Methods
General surgical preparation
Male mice (C57BL/6J, 20–25 g) were housed under di-
urnal lighting conditions and allowed food and tap
water ad libitum. All animal procedures were con-
ducted in accordance with the institutional guidelines
for animal research, and were approved by the University
Animal Care and Use Committee (Permit Number:
PNU-2011-000420). Computer-generated randomization
was conducted using SigmaPlot 11.2 (Systat Software Inc,
San Jose, CA) to allocate organisms to a vehicle and an
EA group. After acquiring a number by computer-
generated randomization, C57BL/6J male mice were al-
located in a blinded fashion. Anesthesia was achieved
by face mask-delivered isoflurane (2 % induction and
1.5 % maintenance, in 80 % N2O and 20 % O2). The
depth of anesthesia was checked by the absence of car-
diovascular changes in response to tail pinch. Rectal
temperature was maintained at 36.5 °C–37.5 °C using a
Panlab thermostatically controlled heating mat (Harvard
Apparatus, Holliston, MA).
EA stimulation
Animals were anesthetized with isoflurane to avoid re-
straint stress. To assess the preconditioning effects of
EA on ischemic brain injury, mice received EA precon-
ditioning for 20 min once a day for three successive days
before the ischemic event (Fig. 1a). The vehicle groups
received only light isoflurane anesthesia for 20 min. The
transpositional method, which locates the veterinary
Fig. 1 EA preconditioning reduced infarct size and improved
neurological and motor function after focal cerebral ischemia.
a A schematic diagram illustrating the chronological events of
experiments. The mice received 20 min EA preconditioning once
a day for three days prior to the ischemic event, after which focal
cerebral ischemia was induced by middle cerebral artery occlusion
(MCAO). b Mouse schematic showing the location of the acupuncture
points used in the study. GV20 stands for ‘Baihui’, which is located at
the right midpoint of the parietal bone. GV14 stands for ‘Dazhui’,
which is located on the posterior midline and in the depression
below the spinous process of the seventh cervical vertebra.
c Representative photographs of coronal brain sections stained
with 2,3,5-triphenyltetrazolium chloride (TTC) in vehicle (Veh) and
EA-preconditioned mice. White region indicates the infarct area.
d-f Quantification of the infarct volume (d), neurological deficit (e)
and motor function (f) were assessed 24 h after MCAO in a blinded
fashion. Data are expressed as the means ± SEM (N = 7). *P < 0.05
compared with the vehicle group (Veh)
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acupoints by transforming human acupoints onto animal
anatomy, was used to determine the acupoints in mice
[43]. The acupoint ‘Baihui (GV20)’, which is located at
the right midpoint of the parietal bone, and ‘Dazhui
(GV14)’, which is located on the posterior midline and in
the depression below the spinous process of the seventh
cervical vertebra, were stimulated as standard criteria
Fig. 1b. To accomplish this, acupuncture needles (0.18 ×
30 mm) were inserted into GV20 and GV14 to a depth
of approximately 3 mm, after which they were stimu-
lated at an intensity of 1 mA and a frequency of 2 Hz
for 20 min [16, 23] using a Grass S88 electro stimulator
(Grass Instrument Co., West Warwick, RI). The inten-
sity was maintained just below the level that induced vis-
ible muscle contraction.
Focal cerebral ischemia
Focal cerebral ischemia was induced by MCAO using a
previously described intraluminal filament technique [10].
A fiber-optic probe was affixed to the skull over the MCA
for measurement of the regional cerebral blood flow
(CBF) using a PeriFlux Laser Doppler System 5000
(Perimed, Stockholm, Sweden). Baseline values were
measured before internal carotid artery ligation (consid-
ered to be 100 % flow). MCA occlusion was induced by a
silicon rubber-coated monofilament (Duccol Corporation,
Redlands, CA) in the internal carotid artery, after which
the monofilament was advanced to occlude the MCA.
In all animals, the regional CBF was measured to con-
firm achievement of consistent and similar levels of is-
chemic induction. The filament was withdrawn 1 h
after occlusion and reperfusion was confirmed using
the laser Doppler. The surgical wound was sutured and
mice were allowed to recover from anesthesia. The brains
were removed 24 h after MCA occlusion. Cerebral infarct
size was determined on 2,3,5-triphenyltetrazolium chlor-
ide (TTC)-stained, 2-mm-thick brain sections. Infarction
areas were quantified using the iSolution full image
analysis software (Image & Microscope Technology,
Vancouver, Canada). To account for and eliminate the
effects of swelling/edema, infarction volume was calculated
via indirect measurement by summing the volumes of each
section according to the following formula: contralateral
hemisphere (mm3) - undamaged ipsilateral hemisphere
(mm3) [24].
Neurological score
Neurological deficit was scored in each mouse at 24 h
after the ischemia reperfusion insult in a blinded fashion
according to the following graded scoring system: 0 = no
deficit; 1 = forelimb weakness and torso turning to the
ipsilateral side when held by tail; 2 = circling to the af-
fected side; 3 = unable to bear weight on the affected
side; and 4 = no spontaneous locomotor activity or barrel
rolling [22].
Rota-rod test
Motor coordination and equilibrium were measured
24 h after cerebral ischemia using a rota-rod apparatus
(Panlab S.L.U., Barcelona, Spain). After adaptation trials,
each mouse was placed on the rotating rod for five trials
at a speed of 18 rpm for 3 min and the time that an ani-
mal was able to hold itself on the rod was recorded.
Detection of superoxide anion
ROS production in the brain was assessed using in vivo
dihydroethidium (DHE, Life Technologies, Eugene, OR)
staining. DHE, a cell-permeable oxidative-sensitive
fluorescent dye, is oxidized to ethidium by superoxide,
which, subsequently binds to DNA in the nucleus and
emits red fluorescence. The frozen brains were cut at a
thickness of 14 μm using a CM 3050 cryostat (Leica
Microsystems), after which the sections were incubated
with DHE (50 μM) in PBS for 10 min at 37 °C in a hu-
midified chamber protected from light. The images of
each section were captured with a Zeiss LSM 700 laser
scanning confocal device (Carl Zeiss, Jena, Germany)
and quantification of DHE-positive cells in three cor-
onal sections in each animal was analyzed using the
Image J program.
Real-time PCR
Mice were deeply anesthetized with sodium thiopental
24 h after the induction of ischemia, after which they
were perfused transcardially with cold PBS and the brain
cortexes were collected. Total RNA was isolated from
the ischemic cortex using TRIzol reagentTM (Invitrogen,
Carlsbad, CA) according to the manufacturer’s recom-
mendations. The RNA was then reverse-transcribed for
1 h at 42 °C with Moloney Murine Leukemia Virus re-
verse transcriptase (Promega, Madison, WI) to produce
cDNA. Real-time PCR was performed to quantify the
amount of NOX2 and NOX4 mRNA in the ischemic
brain using a Rotor-Gene Q real-time PCR system (Qiagen,
Hilden, Germany) with SYBR Green PCR Master Mix
(Qiagen), after which the results were normalized to
GAPDH gene expression. All experiments were performed
in triplicate and repeated at least three times. The follow-
ing primer sequences were used:
mouse Nox2 -557 to-725 (175 bp), 5′-CTGAAGGGG
GCCTGTATGTG-3′ (forward)-, and 5′-ATGGCAA
GGCCGATGAAGAA-3′ (reverse);
mouse Nox4 -2478 to −5896 (119 bp), 5′-CCTCGCT
GCAGTGTTCCTAA-3′ (forward)-, and 5′-GATTG
GCTAAGGGGGAGCAG-3′ (reverse).
Jung et al. Journal of Biomedical Science  (2016) 23:32 Page 3 of 11
The threshold cycles (Ct) were used to quantify the
mRNA expression of target genes.
Western blotting
Proteins were subsequently isolated from the ischemic
cortex according to the standard methods, separated by
12 % sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis, and transferred onto a nitrocellulose membrane
(Amersham Biosciences, Piscataway, NJ). Next, immuno-
blot analysis was performed with primary antibodies NOX2
(Abcam, Cambridge, UK), NOX4 antibody (Abcam),
ZO-1 (Invitrogen Corporation, Carlsbad, CA), occludin
(Invitrogen Corporation) and claudin-5 (Invitrogen
Corporation) at 4 °C overnight, followed by horseradish
peroxidase-conjugated anti-rabbit secondary antibody
(Enzo, Farmingdale, NY) for 1 h. The intensity of
chemiluminescence was measured using an ImageQuant
LAS 4000 apparatus (GE Healthcare Life Sciences, Uppsala,
Sweden). The membrane was then reprobed with anti-β-
actin (Sigma-Aldrich) antibody as an internal control.
Immunofluorescence staining
At 24 h after focal cerebral ischemia, mice were deeply
anesthetized with sodium thiopental and subsequently
perfused transcardially with cold PBS followed by 4 %
paraformaldehyde for fixation. The brain of each mouse
was then removed and further fixed in 4 % paraformal-
dehyde at 4 °C for 24 h, followed by cryoprotection in
30 % sucrose for 72 h at 4 °C. Next, the isolated brains
were frozen in an optical cutting temperature medium
for frozen tissue specimens (Sakura Finetek, Torrance,
CA) and stored at −80 °C until examined. The frozen
brains were cut at a thickness of 14 μm using a CM
3050 cryostat (Leica Microsystems, Wetzlar, Germany),
after which the sections were immunostained with pri-
mary antibodies against GFAP (Dako, Glostrup, Denmark)
and AQP4 (R&D Systems, Minneapolis, MN) at 4 °C. Fol-
lowing overnight incubation, the samples were incubated
with FITC- or Texas red-conjugated secondary antibodies
(Vector Laboratories, Inc., Burlingame, CA) for 2 h in the
dark. The images of each section were captured with a
Zeiss LSM 700 laser scanning confocal device (Carl Zeiss,
Jena, Germany) and morphological analysis and quantifi-
cation of positive cells was conducted using the Image J
program. Positive cells were counted in random fields of
view in the periinfarct area by an investigator blinded to
the treatment groups. Counting was done in three ad-
jacent brain sections. Three fields per predefined area
of each brain section were counted for GFAP and
AQP4 staining.
Evans blue extravasation and water content
BBB integrity was evaluated by Evans blue extravasation.
Briefly, Evans blue (2 % in saline, 4 ml/kg; Sigma-Aldrich)
was administered intravenously at the onset of ischemia.
Mice were deeply anesthetized with sodium thiopental,
then transcardially perfused with PBS to remove the
intravascular dye 24 h after cerebral ischemia. Next,
each hemisphere was weighed, homogenized in 2 ml of
N,N-dimethylformamide (Sigma-Aldrich), incubated for
24 h at 55 °C, and then centrifuged (13,000 rpm for
20 min). The absorbance of the supernatant at 620 nm
was subsequently measured by spectrophotometry and
the results were expressed as μg/g tissue calculated against
a standard curve. The brain tissue water content was also
measured by the wet and dry weight method 24 h after
cerebral ischemia. To accomplish this, the hemispheres
were weighed before and after drying at 100 °C for 48 h,
and the percentage water content was calculated as
100 × (wet weight-dry weight)/wet weight.
Data analysis
The data are expressed as the means ± the standard
error of mean (SEM). The vehicle group was compared
to the group treated with EA by unpaired t-tests. Differ-
ences were considered statistically significant, when the
P values were < 0.05. All statistical analyses were per-
formed using SigmaPlot 11.2 (Systat Software Inc).
Results
EA preconditioning attenuates brain damage after focal
cerebral ischemia
To assess whether pretreatment with EA could attenuate
brain damage following focal cerebral ischemia, the mice
received 20 min EA preconditioning once a day for three
days prior to the ischemia-reperfusion injury (Fig. 1a, b).
TTC staining revealed that EA preconditioning signifi-
cantly reduced infarct volume by 42 % from 89.4 ±
9.2 mm3 in the vehicle group to 51.9 ± 10.1 mm3 in the
EA group following transient, 1 h MCA occlusion and
23 h reperfusion (P < 0.05; Fig. 1c, d). Concomitant with
the infarct volume, we found that ischemia-induced
neurological deficits were significantly improved in EA
preconditioned mice 24 h after MCAO (Fig. 1e). In
addition, the rota-rod test revealed that motor deficits
tended to be recovered by EA preconditioning (Fig. 1f ).
These results showed that pretreatment with EA could
improve tissue and functional outcome after ischemic
brain injury.
EA preconditioning prevents ischemia-induced blood-
brain barrier destruction and brain edema
To evaluate BBB permeability after ischemic brain in-
jury, Evans blue extravasation was measured. EA precon-
ditioning significantly reduced Evans blue extravasation
in the ipsilateral hemisphere after focal cerebral ischemia
(P < 0.05; Fig. 2a, b), suggesting that it alleviated the im-
pairment of the BBB induced by cerebral ischemia. To
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examine EA preconditioning effects on post-ischemic
edema formation, we evaluated brain water content at
24 h after reperfusion following MCAO. Concomitant
with the results of Evans blue extravasation, the brain
water content was significantly attenuated by EA precon-
ditioning (13.9 % reduction of vehicle group, P < 0.05;
Fig. 2c), suggesting that it inhibited edema formation fol-
lowing MCAO. To further investigate the mechanism of
BBB disruption, we examined the expression of tight
junction-related proteins ZO-1, occludin and claudin-5 in
the ischemic cortex by Western blotting (Fig. 2d, e). Com-
pared to the vehicle group, EA-pretreated mice displayed
significantly increased expression of two tight junction
proteins, ZO-1 and claudin-5 (Fig. 2d, e), suggesting that
destruction of the BBB after focal cerebral ischemia
was attenuated via increasing tight junction protein
expression.
EA preconditioning reduces astrocyte-AQP4 after ischemic
brain injury
We next determined whether EA preconditioning could
attenuate astrocyte activation after ischemic brain dam-
age by measuring the number of GFAP positive cells in
the ischemic cortex using immunofluorescence (Fig. 3).
The number of GFAP positive cells in the EA precondi-
tioning group was significantly lower than that in the
vehicle group (P < 0.01; Fig. 3b, c), indicating that EA
might inhibit astrocytes in the ischemic cortex. Double
immunofluorescence staining was then used to detect
the expression and localization of aquaporin 4 (AQP4)
in the brain. AQP4 is a water channel expressed in
astrocyte end-feet lining the BBB [1]. AQP4 was highly
expressed in brain of vehicle group and co-expressed in
GFAP-positive cells. The GFAP(+)/AQP4(+) immuno-
fluorescence was significantly reduced in the EA pre-
conditioning group (P < 0.05; Fig. 3b, d). These results
suggest that EA preconditioning could suppress AQP4
expressing astrocytes in ischemic brain.
NOX4, not NOX2, is involved in EA preconditioning
mediated ROS reduction
Excessive production of ROS following cerebral ischemia
has been regard as one of the main causes of BBB dis-
ruption [15]. We observed the ROS production with
DHE, a marker for superoxide (Fig. 4). The intensity
of red fluorescence of DHE-positive cells was markedly re-
duced in the ischemic cortex of the EA preconditioning
group relative to the vehicle group (0.11 ± 0.08-fold,
P < 0.01; Fig. 4b, c). We next examined the two most
important NOX isoforms of superoxide formation, NOX2
and NOX4, by real-time PCR and western blotting (Fig. 5).
Only NOX4 mRNA expression (32.6 ± 2.3 % of the vehicle
group, P < 0.01; Fig. 3b), but not NOX2 mRNA (Fig. 5a,
b), was decreased by EA preconditioning in the ischemic
cortex. We confirmed NOX protein levels in the ischemic
cortex at 24 h after MCAO. Correspondingly, the protein
level of NOX4 was significantly suppressed in EA precon-
ditioning group (66.2 ± 12.0 % of vehicle group, P < 0.05;
Fig. 5c, d). Taken together, these results suggested that EA
preconditioning is a potent suppressor of ROS production
after ischemic injury and NOX4 might have a role in EA
preconditioning mediated ROS reduction.
Discussion
Our study showed that EA preconditioning for three
days prior to ischemia-reperfusion injury significantly re-
duced infarct size and improved neurological function
after focal cerebral ischemia. Staining of DHE showed
Fig. 2 EA preconditioning increased tight junction proteins and
attenuated Evans blue extravasation and brain edema. a Representative
photographs of Evans blue leakage in vehicle or EA-preconditioned
mice brains 24 h after focal cerebral ischemia. The blue area shows
extravasated Evans blue, indicating BBB disruption. b Quantitative
analysis of Evans blue leakage (N = 6, *P < 0.05 compared with the
vehicle group). c Quantitative analysis of water content (N = 5, *P < 0.05
compared with the vehicle group). d Western blots of tight junction
proteins, ZO-1, occludin and claudin-5, in the ischemic cortex 24 h
after focal cerebral ischemia. β-Actin was used as an internal control.
e Densitometric analysis of the western blot bands of ZO-1, occludin
and claudin-5 (N = 4, ** P < 0.01 compared with the vehicle group).
Data are expressed as the means ± SEM. Veh, vehicle group
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that EA preconditioning markedly inhibited superoxide
production in the ischemic cortex, which was accompan-
ied by a reduction of NOX4 expression. Moreover, the re-
sults of immunofluorescence staining showed a significant
decrease in the expression of GFAP(+)/AQP4(+) cells after
cerebral ischemia following EA preconditioning. Regard-
ing the BBB permeability, less Evans blue extravasation
and water contents were observed in the EA precondition-
ing group. In addition, expression of ZO-1 and claudin-5
was increased in the ischemic cortex in response to EA.
Our findings indicated that EA preconditioning could
attenuate cerebral ischemia-reperfusion injury, and the
underlying mechanism was related to reciprocal regula-
tion; down-regulation of NOX4 and ROS production,
while up-regulation of tight junction proteins (Fig. 6).
Pre-conditioning is as a potent endogenous protective
response that activates several endogenous signaling
pathways, resulting in tolerance against ischemia [4]. EA
pretreatment has been shown to induce ischemic toler-
ance mimicking ischemic pretreatment via enhancing
antioxidant activity [45], regulation of the endocannabi-
noid system [36, 37] and neurotrophic factors [17] and
involvement of adenosine receptor [38] and opiod recep-
tors [39], suggesting that EA pretreatment may be a
promising preventive strategy for patients with high risk
of acute ischemia brain injury. Since EA is economical,
easily performed, and has low side effects, it is clinically
applicable for prevention, and not just treatment of ische-
mic stroke. This study demonstrated that, similar to the is-
chemic tolerance induced by ischemic preconditioning,
20 min of EA treatment once a day for three days prior to
the ischemia-reperfusion injury significantly decreased in-
farct volume and improved neurological function after
focal cerebral ischemia in mice (Fig. 1). Thus, the results
Fig. 3 EA preconditioning reduced AQP4 expressing astrocytes after focal cerebral ischemia. a The blue rectangle illustrates the imaging field.
b GFAP (green), AQP4 (red) and DAPI (blue) staining in the peri-infarct area of vehicle or EA-pretreated mouse brains 24 h after focal cerebral
ischemia. Quantification was done in three adjacent brain sections and three fields per predefined area of each brain section were counted for
GFAP and AQP4 staining. The co-expression of AQP4 and GFAP within the same cell is indicated by yellow (merge). c, d Quantification of GFAP(+)
cells (c) or GFAP(+)/AQP4(+) cells (d) in the ischemic cortex. Data are expressed as the means ± SEM (N = 4). *P < 0.05, **P < 0.01 when compared
with the vehicle group (Veh). The scale bar is 50 μm
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from both functional and tissue data suggest that EA
pretreatment could induce tolerance to cerebral ischemic
insult.
Although EA pretreatment could have a preventive ef-
fect against cerebral ischemic injury, there are several
characteristics of EA treatment that differ from other
treatment methods, especially the acupoint specificity.
Previous studies have shown that EA stimuli at the Baihui
acupoint (GV20) efficiently reduced brain infarction and
neurological symptoms [5, 37]. In our study, the Baihui
(GV20) and Dazhui (GV14) acupoints were chosen be-
cause the theory of meridians in traditional Korean
medicine indicates that they are closely related to the
brain and spinal cord and they were commonly used to
treat stroke in ancient Korea. Recently, there are sev-
eral papers that EA stimuli at the Baihui and Dazhui
acupoints have a protective effect on ischemic brain
damage using different ischemia models (MCAO model
and photothrombotic cortical infarction model) and
different animals (rats and mice) [3, 17, 18]. In the
present study, treatment of EA stimulation at GV20
and GV14 before focal cerebral ischemia improves tissue
and functional recovery. However, this finding raises the
concern that the recovery effects were not mediated by
acupuncture, but by electrical stimulation. As a negative
control, we investigated the mice received the same
electrical stimulation at non-acupuncture points in our
previous publication [16]. We observed that the mice re-
ceived the same electrical stimulation at non-acupuncture
points (lateral points to aforementioned acupoint by
approximately 1 mm apart) did not show any protective
responses [16]. This result suggested that the effects of
EA at GV20 and GV14 cannot be attributed to electrical
stimulation alone.
Fig. 4 EA preconditioning reduced ROS production after focal cerebral ischemia. a The blue rectangle illustrates the imaging field. b Dihydroethidium
(DHE, red, arrows) fluorescence images show the superoxide signal taken from the ischemic cortex 24 h after focal cerebral ischemia. The
mice received EA (20 min) once a day for three days prior to the ischemic event. DAPI (blue), nucleus. Scale bar is 50 μm. c Quantification
was done in three adjacent brain sections and three fields per predefined area of each brain section were counted for DHE staining in the
ischemic cortex. Data are expressed as the means ± SEM (N = 4). ** P < 0.01 when compared with the vehicle group (Veh)
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Several researchers have demonstrated that the block-
ade of free radicals and vasogenic edema may be respon-
sible for the therapeutic action of EA [33, 34, 44].
Induced excessive production of ROS represents the
major mechanism contributing BBB disruption following
ischemic stroke [39]. In addition, NOXs are the major
sources of ROS that lead to BBB disruption following
cerebral ischemia [13]. It is well known that there are
three types of NOXs expressed in the central nerve sys-
tem: NOX1, NOX2, and NOX4 [12]. Of these, NOX2
and NOX4 are upregulated within 24 h, after which sub-
sequent ROS generation contributes to BBB disruption,
inflammation, and post-ischemic neuronal injury [8, 21].
In addition, NOX4 KO mice showed profoundly reduced
oxidative stress, BBB dysfunction, and neuronal apop-
tosis 24 h after transient MCAO, whereas deficiency of
NOX1 or NOX2 had no impact on infarct size or func-
tional outcome [21]. Therefore, preventing the gener-
ation of ROS early in the process by blocking NOX4
might be a potential therapeutic strategy for treatment
of ischemic stroke.
Previous studies indicated that EA increased the acti-
vation of anti-oxidant enzymes [33, 34] and inhibited
oxidative stress in ischemic injury [2]. Thus, our study
suggests that the preventive effects of EA on brain
ischemic injury involve its ability to attenuate BBB dis-
ruption and brain edema (Fig. 2), and that this BBB
protection may involve the suppression of NOX4 expres-
sion and ROS production (Figs. 4, 5). Our results were
supported by a recent report that EA pretreatment inhibits
NOX-mediated oxidative stress in diabetic mice with cere-
bral ischemia [9]. Therefore, we suggest that decreasing
ROS generation with NOX4 expression is the underlying
mechanism of EA protection following focal cerebral
ischemia. Because EA remarkably decreased NOX4 ex-
pression (Fig. 5), it might be interesting how EA regu-
late NOX4 expression. We searched for transcription
factor binding sites in the NOX4 gene promoter using
the bioinformatics site (www.genecards.org). We specu-
lated that the transcription factors for NOX4 expression
are suppressed by EA. The binding sites for ATF-2, AP-1,
c-Jun, Nkx2.5 and p53 exist in NOX4 promoter region
(www.genecards.org). Interestingly, EA down-regulates
the ATF-2 protein expression in a rat model of inflamma-
tory pain and reduce the inflammatory pain [7]. In the in-
flammatory rat model, EA decreases p-c-Jun protein level
and the DNA binding activity of AP-1 [6]. In addition, EA
exerts anti-apoptotic effects in rat cerebral ischemia
model, and EA protects against pyramidal cell death by
blocking p53 expression in vascular dementia rats [19, 46].
The mechanism involvement in the down-regulation of
NOX4 by EA is less clear. However, we believe that the
EA-mediated suppression of regulatory factors such as
ATF-2, AP-1, c-Jun and p53 may be among the contribut-
ing factors. Further research is needed to clarify this issue.
AQP4 is the most abundant water channel in brain tissue,
especially in perivascular end-feet of astrocytes lining the
BBB and brain-cerebrospinal fluid interfaces [28]. An
increase in AQP4 expression may aggravate injury to
endothelial cells and tight junctions, promote BBB destruc-
tion, and lead to water entering brain tissues, resulting in
an increase in brain water content and the formation of
brain edema. Cerebral edema is a major and potential fatal
complication of acute ischemic stroke. There is accumulat-
ing evidence that cerebral ischemia upregulates AQP4 ex-
pression, increases BBB permeability, and induces brain
edema, which exacerbates ischemic brain injury [30]. AQP4
immunoreactivity was found to be increased with brain
edema formation in human autopsy [1], and AQP4 knock-
out mice ameliorate brain swelling and improve outcome
following ischemia [14, 26], while an accelerated pro-
gression of cytotoxic brain swelling was observed in
mice overexpressing glial cell AQP4 [41]. In addition,
the AQP4 inhibitor, TGN-020, ameliorated cerebral edema
in ischemic mouse brain [11], while mesenchymal stem
cells maintained BBB integrity by inhibiting AQP4 upreg-
ulation after cerebral ischemia [35]. Thus, regulation of
AQP4 after cerebral ischemia might provide a therapeutic
option for reducing brain edema. EA was recently
Fig. 5 EA preconditioning down-regulated the expression of NOX4,
not NOX2, after focal cerebral ischemia. a, b Real-time PCR shows
the mRNA levels of NOX2 and NOX4 in the ischemic brain tissues
24 h after focal cerebral ischemia. (N = 4, ** P < 0.01 compared with
the vehicle group). c Western blots of NOX2 and NOX4 in the ischemic
cortex 24 h after focal cerebral ischemia. β-Actin was used as an
internal control. d Densitometric quantification graph of the western
blot bands of NOX4. Data are expressed as the means ± SEM (N = 4).
*P < 0.05 when compared with the vehicle group (Veh)
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reported to significantly attenuate expression of the
water channel proteins, AQP4 and AQP9, in the ische-
mic brain [40]. In addition, EA markedly reduced
neurological deficits, decreased corpus striatum AQP4
protein and mRNA expression, and relieved damage to
the BBB in a rat model of cerebral ischemia-reperfusion
injury [31]. We observed that the numbers of GFAP(+)/
AQP4(+) cells were significantly lower at the cortical
border zone in the EA preconditioning group (Fig. 3). This
finding also indicated that the neuroprotective mechanism
of EA preconditioning could be related to the down-
regulation of AQP4(+) astrocytes.
After ischemic brain injury, the BBB integrity was dis-
rupted, which was followed by an increase in vascular
permeability and brain edema and secondary brain injury,
exacerbating the initial ischemic injury [27]. Therefore,
maintenance of BBB integrity has been one of major tar-
gets for protecting the brain from ischemic stroke. Tight
junction proteins are the core portions of the BBB, which
is located in the tightly sealed monolayer of brain endo-
thelial cells [29]. Tight junction proteins such as ZO-1,
occludin and claudin-5 have been shown to be reduced in
experimental neurological disease models, which conse-
quently compromised the integrity of the BBB [20]. In
addition, experimental evidence and clinical data suggest
that ROS disrupt the BBB by degrading the tight junctions
[32]. EA pretreatment for five days was recently shown to
significantly reduce BBB permeability and brain edema,
which were correlated with alleviation of the degradation
of tight junction proteins occludin and claudin-5 following
cerebral ischemia-reperfusion in rats [47]. We here dem-
onstrated that EA pretreatment increased the expression
of tight junction protein such as ZO-1 and claudin-5,
which corresponded to its protective effect against BBB
disruption and edema in cerebral ischemic brains (Fig. 2).




blood vessel  














Fig. 6 Schematic representation of the importance of EA preconditioning for attenuating cerebral ischemia-reperfusion injury
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that showed EA can alleviate cerebral edema of rats after
ischemia using diffusion-weighted MRI [44]. Dong et al.
also observed that EA preconditioning protected BBB
integrity and brain edema via reduction of MMP-9 ex-
pression and activity [5]. Therefore, BBB destruction
and brain edema after ischemic brain injury could be
effectively rescued by EA pretreatment, at least a result
of increased expression of ZO-1 and claudin-5.
Conclusions
Our current study revealed the effectiveness and mechan-
ism of EA preconditioning on the reduction of infarct vol-
ume and neurological deficits after ischemia-reperfusion
injury. We demonstrated that EA preconditioning can
delay or ameliorate the development of ischemic brain
edema, and that this may be achieved via down-regulation
of ROS generation, NOX4 expression and AQP4(+) astro-
cytes. Moreover, EA preconditioning up-regulates tight
junction proteins, resulting in cerebral ischemia tolerance.
Therefore, decreasing BBB disruption and brain edema via
regulating NOX4 expression and ROS production by EA
preconditioning may be an effective preventive strategy
for reducing further ischemic brain damage.
Competing interests
The authors declare no competing financial interests.
Authors’ contributions
Participated in research design: YSJ, BTC and HKS. Conducted experiments:
YSJ, JHP and HBS. Contributed new reagents or analytic tools: YSJ and S-WL.
Performed data analysis: YSJ, S-WL and HKS. Wrote or contributed to the
writing of the manuscript: S-WL, BTC and HKS. All authors read and approved
the final manuscript.
Acknowledgements
This work was supported by the National Research Foundation of Korea
(NRF) grant funded by the Ministry of Education, Science and Technology
(2013R1A1A2005824) and the Korea government (MSIP) (2014R1A5A2009936).
Author details
1Korean Medical Science Research Center for Healthy-Aging, Pusan National
University, Yangsan, Gyeongnam 626-870, Republic of Korea. 2Department of
Korean Medical Science, School of Korean Medicine, Pusan National
University, Yangsan, Gyeongnam 626-870, Republic of Korea. 3Division of
Meridian and Structural Medicine, School of Korean Medicine, Pusan National
University, Yangsan, Gyeongnam 626-870, Republic of Korea.
Received: 3 December 2015 Accepted: 19 February 2016
References
1. Aoki K, Uchihara T, Tsuchiya K, Nakamura A, Ikeda K, Wakayama Y. Enhanced
expression of aquaporin 4 in human brain with infarction. Acta Neuropathol.
2003;106(2):121–4.
2. Chen Y, Zhou J, Li J, Yang SB, Mo LQ, Hu JH, Yuan WL. Electroacupuncture
pretreatment prevents cognitive impairment induced by limb ischemia-
reperfusion via inhibition of microglial activation and attenuation of
oxidative stress in rats. Brain Res. 2012;1432:36–45.
3. Cheng CY, Lin JG, Tang NY, Kao ST, Hsieh CL. Electroacupuncture-like
stimulation at the Baihui (GV20) and Dazhui (GV14) acupoints protects rats
against subacute-phase cerebral ischemia-reperfusion injuries by reducing
S100B-mediated neurotoxicity. PLoS One. 2014;9(3), e91426.
4. Dirnagl U, Becker K, Meisel A. Preconditioning and tolerance against
cerebral ischaemia: from experimental strategies to clinical use. Lancet
Neurol. 2009;8(4):398–412.
5. Dong H, Fan YH, Zhang W, Wang Q, Yang QZ, Xiong LZ. Repeated
electroacupuncture preconditioning attenuates matrix metalloproteinase-9
expression and activity after focal cerebral ischemia in rats. Neurol Res.
2009;31(8):853–8.
6. Du JY, Fang JQ, Liang Y, Fang JF. Electroacupuncture attenuates mechanical
allodynia by suppressing the spinal JNK1/2 pathway in a rat model of
inflammatory pain. Brain Res Bull. 2014;108:27–36.
7. Fang JQ, Du JY, Liang Y, Fang JF. Intervention of electroacupuncture on
spinal p38 MAPK/ATF-2/VR-1 pathway in treating inflammatory pain
induced by CFA in rats. Mol Pain. 2013;9:13.
8. Green SP, Cairns B, Rae J, Errett-Baroncini C, Hongo JA, Erickson RW, et al.
Induction of gp91-phox, a component of the phagocyte NADPH oxidase, in
microglial cells during central nervous system inflammation. J Cereb Blood
Flow Metab. 2001;21(4):374–84.
9. Guo F, Song W, Jiang T, Liu L, Wang F, Zhong H, Yin H, Wang Q, Xiong L.
Electroacupuncture pretreatment inhibits NADPH oxidase-mediated oxidative
stress in diabetic mice with cerebral ischemia. Brain Res. 2014;1573:84–91.
10. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA.
Effects of cerebral ischemia in mice deficient in neuronal nitric oxide
synthase. Science. 1994;265(5180):1883–5.
11. Igarashi H, Huber VJ, Tsujita M, Nakada T. Pretreatment with a novel
aquaporin 4 inhibitor, TGN-020, significantly reduces ischemic cerebral
edema. Neurol Sci. 2011;32(1):113–6.
12. Infanger DW, Sharma RV, Davisson RL. NADPH oxidases of the brain: distribution,
regulation, and function. Antioxid Redox Signal. 2006;8(9–10):1583–96.
13. Kahles T, Luedike P, Endres M, Galla HJ, Steinmetz H, Busse R, Neumann-
Haefelin T, Brandes RP. NADPH oxidase plays a central role in blood–brain
barrier damage in experimental stroke. Stroke. 2007;38(11):3000–6.
14. Katada R, Akdemir G, Asavapanumas N, Ratelade J, Zhang H, Verkman AS.
Greatly improved survival and neuroprotection in aquaporin-4-knockout
mice following global cerebral ischemia. FASEB J. 2014;28(2):705–14.
15. Khan M, Dhammu TS, Sakakima H, Shunmugavel A, Gilg AG, Singh AK,
Singh I. The inhibitory effect of S-nitrosoglutathione on blood–brain barrier
disruption and peroxynitrite formation in a rat model of experimental
stroke. J Neurochem. 2012;123 Suppl 2:86–97.
16. Kim JH, Choi KH, Jang YJ, Bae SS, Shin BC, Choi BT, Shin HK.
Electroacupuncture acutely improves cerebral blood flow and attenuates
moderate ischemic injury via an endothelial mechanism in mice. PLoS One.
2013;8(2), e56736.
17. Kim JH, Choi KH, Jang YJ, Kim HN, Bae SS, Choi BT, Shin HK.
Electroacupuncture preconditioning reduces cerebral ischemic injury via
BDNF and SDF-1alpha in mice. BMC Complement Altern Med. 2013;13:22.
18. Kim YR, Kim HN, Ahn SM, Choi YH, Shin HK, Choi BT. Electroacupuncture
promotes post-stroke functional recovery via enhancing endogenous
neurogenesis in mouse focal cerebral ischemia. PLoS One. 2014;9(2), e90000.
19. Kim YR, Kim HN, Jang JY, Park C, Lee JH, Shin HK, Choi YH, Choi BT. Effects
of electroacupuncture on apoptotic pathways in a rat model of focal
cerebral ischemia. Int J Mol Med. 2013;32(6):1303–10.
20. Kirk J, Plumb J, Mirakhur M, McQuaid S. Tight junctional abnormality in multiple
sclerosis white matter affects all calibres of vessel and is associated with blood–
brain barrier leakage and active demyelination. J Pathol. 2003;201(2):319–27.
21. Kleinschnitz C, Grund H, Wingler K, Armitage ME, Jones E, Mittal M, Barit D,
Schwarz T, Geis C, Kraft P, Barthel K, Schuhmann MK, Herrmann AM, Meuth
SG, Stoll G, Meurer S, Schrewe A, Becker L, Gailus-Durner V, Fuchs H,
Klopstock T, de Angelis MH, Jandeleit-Dahm K, Shah AM, Weissmann N. and
Schmidt HH. Post-stroke inhibition of induced NADPH oxidase type 4
prevents oxidative stress and neurodegeneration. PLoS Biol 8(9), 2010.
22. Li X, Blizzard KK, Zeng Z, DeVries AC, Hurn PD, McCullough LD. Chronic
behavioral testing after focal ischemia in the mouse: functional recovery
and the effects of gender. Exp Neurol. 2004;187(1):94–104.
23. Li X, Luo P, Wang Q, Xiong L. Electroacupuncture Pretreatment as a Novel
Avenue to Protect Brain against Ischemia and Reperfusion Injury. Evid Based
Complement Alternat Med. 2012;2012:195397.
24. Lin TN, He YY, Wu G, Khan M, Hsu CY. Effect of brain edema on infarct
volume in a focal cerebral ischemia model in rats. Stroke. 1993;24(1):117–21.
25. Liu H, Shen X, Tang H, Li J, Xiang T, Yu W. Using microPET imaging in
quantitative verification of the acupuncture effect in ischemia stroke
treatment. Sci Rep. 2013;3:1070.
Jung et al. Journal of Biomedical Science  (2016) 23:32 Page 10 of 11
26. Manley GT, Fujimura M, Ma T, Noshita N, Filiz F, Bollen AW, Chan P,
Verkman AS. Aquaporin-4 deletion in mice reduces brain edema after acute
water intoxication and ischemic stroke. Nat Med. 2000;6(2):159–63.
27. Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in
search of treatments. Neuron. 2010;67(2):181–98.
28. Nielsen S, Nagelhus EA, Amiry-Moghaddam M, Bourque C, Agre P, Ottersen OP.
Specialized membrane domains for water transport in glial cells:
high-resolution immunogold cytochemistry of aquaporin-4 in rat brain.
J Neurosci. 1997;17(1):171–80.
29. Ohtsuki S, Terasaki T. Contribution of carrier-mediated transport systems to
the blood–brain barrier as a supporting and protecting interface for the
brain; importance for CNS drug discovery and development. Pharm Res.
2007;24(9):1745–58.
30. Papadopoulos MC, Verkman AS. Aquaporin-4 and brain edema. Pediatr
Nephrol. 2007;22(6):778–84.
31. Peng Y, Wang H, Sun J, Chen L, Xu M, Chu J. Electroacupuncture reduces
injury to the blood–brain barrier following cerebral ischemia/ reperfusion
injury. Neural Regen Res. 2012;7(36):2901–6.
32. Sandoval KE, Witt KA. Blood–brain barrier tight junction permeability and
ischemic stroke. Neurobiol Dis. 2008;32(2):200–19.
33. Siu FK, Lo SC, Leung MC. Electro-acupuncture potentiates the disulphide-
reducing activities of thioredoxin system by increasing thioredoxin
expression in ischemia-reperfused rat brains. Life Sci. 2005;77(4):386–99.
34. Siu FK, Lo SC, Leung MC. Electroacupuncture reduces the extent of lipid
peroxidation by increasing superoxide dismutase and glutathione peroxidase
activities in ischemic-reperfused rat brains. Neurosci Lett. 2004;354(2):158–62.
35. Tang G, Liu Y, Zhang Z, Lu Y, Wang Y, Huang J, Li Y, Chen X, Gu X, Wang Y,
Yang GY. Mesenchymal stem cells maintain blood–brain barrier integrity by
inhibiting aquaporin-4 upregulation after cerebral ischemia. Stem Cells.
2014;32(12):3150–62.
36. Wang Q, Li X, Chen Y, Wang F, Yang Q, Chen S, Min Y, Xiong L. Activation
of epsilon protein kinase C-mediated anti-apoptosis is involved in rapid
tolerance induced by electroacupuncture pretreatment through
cannabinoid receptor type 1. Stroke. 2011;42(2):389–96.
37. Wang Q, Peng Y, Chen S, Gou X, Hu B, Du J, Lu Y, Xiong L. Pretreatment
with electroacupuncture induces rapid tolerance to focal cerebral ischemia
through regulation of endocannabinoid system. Stroke. 2009;40(6):2157–64.
38. Wang Q, Xiong L, Chen S, Liu Y, Zhu X. Rapid tolerance to focal cerebral
ischemia in rats is induced by preconditioning with electroacupuncture:
window of protection and the role of adenosine. Neurosci Lett.
2005;381(1–2):158–62.
39. Xiong LZ, Yang J, Wang Q, Lu ZH. Involvement of delta-and mu-opioid
receptors in the delayed cerebral ischemic tolerance induced by repeated
electroacupuncture preconditioning in rats. Chin Med J (Engl). 2007;120(5):394–9.
40. Xu H, Zhang Y, Sun H, Chen S, Wang F. Effects of acupuncture at GV20 and
ST36 on the expression of matrix metalloproteinase 2, aquaporin 4, and
aquaporin 9 in rats subjected to cerebral ischemia/reperfusion injury. PLoS
One. 2014;9(5), e97488.
41. Yang B, Zador Z, Verkman AS. Glial cell aquaporin-4 overexpression
in transgenic mice accelerates cytotoxic brain swelling. J Biol Chem.
2008;283(22):15280–6.
42. Yang Y, Rosenberg GA. Blood–brain barrier breakdown in acute and chronic
cerebrovascular disease. Stroke. 2011;42(11):3323–8.
43. Yin CS, Jeong HS, Park HJ, Baik Y, Yoon MH, Choi CB, Koh HG. A proposed
transpositional acupoint system in a mouse and rat model. Res Vet Sci.
2008;84(2):159–65.
44. Zhang F, Wu Y, Jia J. Electro-acupuncture can alleviate the cerebral oedema
of rat after ischemia. Brain Inj. 2011;25(9):895–900.
45. Zhong S, Li Z, Huan L, Chen BY. Neurochemical Mechanism of
Electroacupuncture: Anti-injury Effect on Cerebral Function after Focal
Cerebral Ischemia in Rats. Evid Based Complement Alternat Med.
2009;6(1):51–6.
46. Zhu Y, Zeng Y. Electroacupuncture protected pyramidal cells in
hippocampal CA1 region of vascular dementia rats by inhibiting the
expression of p53 and Noxa. CNS Neurosci Ther. 2011;17(6):599–604.
47. Zou R, Wu Z, Cui S. Electroacupuncture pretreatment attenuates bloodbrain
barrier disruption following cerebral ischemia/reperfusion. Mol Med Rep.
2015;12(2):2027–34.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Jung et al. Journal of Biomedical Science  (2016) 23:32 Page 11 of 11
